{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:46:46Z","timestamp":1791373606935,"version":"4.3.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Approval for the use of COVID-19 vaccines has been granted in a number of countries but there are concerns that vaccine uptake may be low amongst certain groups.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    This study used a mixed methods approach based on online survey and an embedded quantitative\/qualitative design to explore perceptions and attitudes that were associated with intention to either accept or refuse offers of vaccination in different demographic groups during the early stages of the UK's mass COVID-19 vaccination programme (December 2020). Analysis used multivariate logistic regression, structural text modeling and anthropological assessments.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Of 4,535 respondents, 85% (\n                    <jats:italic>n<\/jats:italic>\n                    = 3,859) were willing to have a COVID-19 vaccine. The rapidity of vaccine development and uncertainties about safety were common reasons for COVID-19 vaccine hesitancy. There was no evidence for the widespread influence of mis-information, although broader vaccine hesitancy was associated with intentions to refuse COVID-19 vaccines (OR 20.60, 95% CI 14.20\u201330.30,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001). Low levels of trust in the decision-making (OR 1.63, 95% CI 1.08, 2.48,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.021) and truthfulness (OR 8.76, 95% CI 4.15\u201319.90,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001) of the UK government were independently associated with higher odds of refusing COVID-19 vaccines. Compared to political centrists, conservatives and liberals were, respectively, more (OR 2.05, 95%CI 1.51\u20132.80,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001) and less (OR 0.30, 95% CI 0.22\u20130.41,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001) likely to refuse offered vaccines. Those who were willing to be vaccinated cited both personal and public protection as reasons, with some alluding to having a sense of collective responsibility.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Dominant narratives of COVID-19 vaccine hesitancy are misconceived as primarily being driven by misinformation. Key indicators of UK vaccine acceptance include prior behaviors, transparency of the scientific process of vaccine development, mistrust in science and leadership and individual political views. Vaccine programmes should leverage the sense of altruism, citizenship and collective responsibility that motivated many participants to get vaccinated.\n                  <\/jats:p>","DOI":"10.3389\/fpubh.2021.745630","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T02:05:28Z","timestamp":1636596328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Vaccine Confidence and Hesitancy at the Start of COVID-19 Vaccine Deployment in the UK: An Embedded Mixed-Methods Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Chrissy h.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina T.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Enria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med."},{"key":"B4","unstructured":"2021"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.01.21252652","article-title":"Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England","author":"Bernal","year":"2021","journal-title":"medRxiv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/ije\/dyab057","article-title":"HOSTED\u2014England's household transmission evaluation dataset: preliminary findings from a novel passive surveillance system of COVID-19","volume":"50","author":"Hall","year":"2021","journal-title":"Int J Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJMc2107717","article-title":"Effect of vaccination on household transmission of SARS-CoV-2 in England","volume":"385","author":"Harris","year":"2021","journal-title":"N Engl J Med."},{"key":"B8","unstructured":"2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S2352-4642(19)30092-6","article-title":"Vaccine hesitancy: a generation at risk","volume":"3","year":"2019","journal-title":"Lancet Child Adolesc Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/21645515.2018.1459252","article-title":"Measuring trust in vaccination: a systematic review","volume":"14","author":"Larson","year":"2018","journal-title":"Hum Vaccin Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"575091","DOI":"10.3389\/fpubh.2020.575091","article-title":"Behavioral change towards reduced intensity physical activity is disproportionately prevalent among adults with serious health issues or self-perception of high risk during the UK COVID-19 lockdown","volume":"8","author":"Rogers","year":"2020","journal-title":"Front Public Health."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.08.20191908","article-title":"Electronic data management for vaccine trials in low resource settings: upgrades, scalability and impact of ODK","author":"Marks","year":"2021","journal-title":"medRxiv."},{"key":"B14","unstructured":"Facebook Business Help Centre2020"},{"key":"B15","unstructured":"2021"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"","journal-title":"J Stat Softw"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v091.i02","article-title":"stm: an R package for structural topic models","volume":"91","author":"Roberts","year":"2019","journal-title":"J Stat Softw."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0239247","DOI":"10.1371\/journal.pone.0239247","article-title":"Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK","volume":"16","author":"Enria","year":"2021","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.lanepe.2020.100012","article-title":"Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications","volume":"1","author":"Paul","year":"2021","journal-title":"Lancet Reg Health Eur."},{"key":"B20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1101\/2020.08.23.20180307","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4161\/hv.24422","article-title":"Race, ethnicity and income as factors for HPV vaccine acceptance and use","volume":"9","author":"Jeudin","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/bmj.39489.590671.25","article-title":"Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study","volume":"336","author":"Pearce","year":"2008","journal-title":"BMJ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1101\/2020.08.13.20174045","article-title":"COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey","volume":"17","author":"Sherman","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0220222","DOI":"10.1371\/journal.pone.0220222","article-title":"A fractionated analysis of hot and cool self-regulation in cigarette smokers from different socioeconomic backgrounds","volume":"14","author":"Antonio","year":"2019","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ypmed.2005.02.001","article-title":"Inequalities in influenza vaccine uptake among people aged over 74 years in Britain","volume":"41","author":"Mangtani","year":"2005","journal-title":"Prev Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.17.20248396","article-title":"Negative vaccine attitudes and intentions to vaccinate against COVID-19 in relation to smoking status: a population survey of UK adults","author":"Jackson","year":"2021","journal-title":"Nicotine Tobacco Res."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.01.20183822","article-title":"Trust and transparency in times of crisis: results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK","author":"Enria","year":"2020","journal-title":"Public Glob Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurpub\/ckz004","article-title":"Populist politics and vaccine hesitancy in Western Europe: an analysis of national-level data","volume":"29","author":"Kennedy","year":"2019","journal-title":"Eur J Public Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"551004","DOI":"10.3389\/fpsyg.2020.551004","article-title":"Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions","volume":"11","author":"Faasse","year":"2020","journal-title":"Front Psychol [Internet]."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.eclinm.2020.100495","article-title":"Determinants of COVID-19 vaccine acceptance in the US","volume":"26","author":"Malik","year":"2020","journal-title":"EClinicalMedicine."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.22.20217513","article-title":"Measuring the impact of exposure to COVID-19 vaccine misinformation on vaccine intent in the UK and US","author":"Loomba","year":"2020","journal-title":"medRxiv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1162\/POSC_a_00223","article-title":"Public misunderstanding of science? Reframing the problem of vaccine hesitancy","volume":"24","author":"Goldenberg","year":"2016","journal-title":"Perspect Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1016\/j.vaccine.2019.09.094","article-title":"Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea","volume":"37","author":"Grantz","year":"2019","journal-title":"Vaccine."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"n1138","DOI":"10.1136\/bmj.n1138","article-title":"Covid-19 vaccination hesitancy","volume":"373","author":"Razai","year":"2021","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(20)32337-0","article-title":"Emergency use authorisation for COVID-19 vaccines: lessons from Ebola","volume":"396","author":"Smith","year":"2020","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.vaccine.2018.12.060","article-title":"Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone","volume":"37","author":"Jendrossek","year":"2019","journal-title":"Vaccine."},{"key":"B40","unstructured":"The Guardian2021"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.17157\/mat.5.4.512","article-title":"Citizens, dependents, sons of the soil","author":"Enria","year":"2018","journal-title":"Med Anthropol Theory."},{"key":"B42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1556264620914463","article-title":"Self-Interested and altruistic motivations in volunteering for clinical trials: a more complex relationship","volume":"15","author":"Olsen","year":"2020","journal-title":"Journal of Empir Res Hum Res Ethics."},{"key":"B43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2213-2600(20)30228-9","article-title":"Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities","volume":"8","author":"Kirby","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1016\/j.vaccine.2020.10.027","article-title":"Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England","volume":"38","author":"Bell","year":"2020","journal-title":"Vaccine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"n1207","DOI":"10.1136\/bmj.n1207","article-title":"What does it mean to engage the public in the response to covid-19?","volume":"373","author":"Scheinerman","year":"2021","journal-title":"BMJ."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.745630\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T02:05:32Z","timestamp":1636596332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.745630\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":45,"alternative-id":["10.3389\/fpubh.2021.745630"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2021.745630","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.13.21260425","asserted-by":"object"}]},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"article-number":"745630"}}